Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin (ASTROH)
Diseases of the Cardiovascular System
What is the purpose of this trial?
A Blind-adjudication Multi-center Phase II Randomized Clinical Trial of Continuous Low-dose Intravenous Heparin Therapy in Coiled Low-grade Aneurysmal Subarachnoid Hemorrhage Patients with Significant Hemorrhage Burden.
- Ages18 years - 70 years
- Trial withUniversity of Louisville
- Start Date06/01/2017
- End Date02/01/2018
- Last Updated07/15/2021
- Study HIC#1601017127